Crescita Therapeutics Stock Price Prediction
| CRRTF Stock | USD 0.45 0.00 0.00% |
Oversold Vs Overbought
91
Oversold | Overbought |
Using Crescita Therapeutics hype-based prediction, you can estimate the value of Crescita Therapeutics from the perspective of Crescita Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Crescita Therapeutics to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Crescita because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Crescita Therapeutics after-hype prediction price | USD 0.45 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Crescita |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Crescita Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Crescita Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Crescita Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Crescita Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Crescita Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Crescita Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Crescita Therapeutics' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Crescita Therapeutics' historical news coverage. Crescita Therapeutics' after-hype downside and upside margins for the prediction period are 0.02 and 72.95, respectively. We have considered Crescita Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Crescita Therapeutics is out of control at this time. Analysis and calculation of next after-hype price of Crescita Therapeutics is based on 3 months time horizon.
Crescita Therapeutics Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Crescita Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Crescita Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Crescita Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
15.84 | 126.00 | 1.04 | 5.78 | 21 Events / Month | 5 Events / Month | In about 21 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.45 | 0.45 | 0.00 |
|
Crescita Therapeutics Hype Timeline
Crescita Therapeutics is currently traded for 0.45. The entity has historical hype elasticity of 1.04, and average elasticity to hype of competition of 5.78. Crescita is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 15.84%. %. The volatility of related hype on Crescita Therapeutics is about 34520.55%, with the expected price after the next announcement by competition of 6.23. The company has price-to-book (P/B) ratio of 0.66. Some equities with similar Price to Book (P/B) outperform the market in the long run. Crescita Therapeutics has Price/Earnings (P/E) ratio of 490.0. The entity had not issued any dividends in recent years. Assuming the 90 days horizon the next anticipated press release will be in about 21 days. Check out Crescita Therapeutics Basic Forecasting Models to cross-verify your projections.Crescita Therapeutics Related Hype Analysis
Having access to credible news sources related to Crescita Therapeutics' direct competition is more important than ever and may enhance your ability to predict Crescita Therapeutics' future price movements. Getting to know how Crescita Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Crescita Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RZLT | Rezolute | (0.28) | 7 per month | 3.08 | 0.03 | 6.81 | (5.54) | 30.01 | |
| TPST | Tempest Therapeutics | (0.09) | 4 per month | 0.00 | (0.13) | 6.38 | (8.53) | 29.55 | |
| FBRX | Forte Biosciences | 3.09 | 5 per month | 3.41 | 0.11 | 6.65 | (6.33) | 126.20 | |
| DYAI | Dyadic International | (0.03) | 7 per month | 3.66 | 0.08 | 9.00 | (7.20) | 16.89 | |
| DMAC | DiaMedica Therapeutics | 0.19 | 6 per month | 2.11 | 0.04 | 4.94 | (3.29) | 10.25 | |
| SILO | Silo Pharma | 0.00 | 0 per month | 0.00 | (0.15) | 6.31 | (10.57) | 23.28 | |
| MOLN | Molecular Partners AG | (0.10) | 5 per month | 5.04 | (0.01) | 9.61 | (8.53) | 52.92 | |
| MLYS | Mineralys Therapeutics, Common | 0.14 | 8 per month | 3.42 | 0.02 | 6.27 | (5.79) | 20.98 |
Crescita Therapeutics Additional Predictive Modules
Most predictive techniques to examine Crescita price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Crescita using various technical indicators. When you analyze Crescita charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Crescita Therapeutics Predictive Indicators
The successful prediction of Crescita Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Crescita Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Crescita Therapeutics based on analysis of Crescita Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Crescita Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Crescita Therapeutics's related companies.
Story Coverage note for Crescita Therapeutics
The number of cover stories for Crescita Therapeutics depends on current market conditions and Crescita Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Crescita Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Crescita Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Crescita Therapeutics Short Properties
Crescita Therapeutics' future price predictability will typically decrease when Crescita Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Crescita Therapeutics often depends not only on the future outlook of the potential Crescita Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Crescita Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 21 M |
Complementary Tools for Crescita Pink Sheet analysis
When running Crescita Therapeutics' price analysis, check to measure Crescita Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crescita Therapeutics is operating at the current time. Most of Crescita Therapeutics' value examination focuses on studying past and present price action to predict the probability of Crescita Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crescita Therapeutics' price. Additionally, you may evaluate how the addition of Crescita Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |